According to Fuji Pharma latest financial reports the total debt is $83.59M, an decrease of -11.36% to 2022. At the end of 2022 company had $94.30M total debt. This figure represents the debts and financial obligations that Fuji Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $83.59M | -11.36% |
2022 | $94.30M | 47.16% |
2021 | $64.08M | 1.18% |
2020 | $63.33M | 19.75% |
2019 | $52.88M | 66.39% |
2018 | $31.78M | - |